Hydrochlorothiazide is superior to isradipine for reduction of left ventricular mass: Results of a multicenter trial

Journal of the American College of Cardiology

Volumn 30, Issue 7, 1997, Pages 1802-1808

  Papademetriou, Vasilios ^a   Gottdiener, John S ^a   Narayan, Puneet ^a   Cushman, William G ^b   Zachariah, Prince K ^c   Gottdiener, Patricia S ^a   Chase, Gary A ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCHLOROTHIAZIDE; ISRADIPINE;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ELECTROCARDIOGRAM; FEMALE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DIURETICS; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; ISRADIPINE; MALE; MIDDLE AGED; SODIUM CHLORIDE SYMPORTER INHIBITORS; TIME FACTORS;

EID: 0031541514     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00311-2     Document Type: Article

References (36)

1. Koren MJ, Devereux RB, Casale PN. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 114:1991;345-352.
2. Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med. 117:1992;831-836.
3. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 322:1990;1561-1566.
4. Levy D, Salomon M, D'Agostino R, Belanger A, Kannel W. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation. 90:1994;1786-1793.
5. Yuranev AP, Dyakonova HG, Novikov ID, et al. Management of essential hypertension in patients with different degrees of left ventricular hypertrophy multicenter trial . Am J Hypertens. 5:1992;182S-189S.
6. Fouad-Tarazi F, Liebson PR. Echocardiographic studies of regression of left ventricular hypertrophy in hypertension. Hypertension. 4:(Suppl 2):1987;65-68.
7. Dittrich HC, Adler J, Ong J, Reitman M, Weber M, Ziegler M. Effects of sustained-release nicardipine on regression of left ventricular hypertrophy in systemic hypertension. Am J Cardiol. 69:1992;1559-1564.
8. Phillips RA, Ardeljan M, Shimabukuro S, et al. Normalization of left ventricular mass and associated changes in neurohormones and atrial natriuretic peptide after 1 year of sustained nifedipine therapy for severe hypertension. J Am Coll Cardiol. 17:1991;1595-1602.
9. Carr AA, Prisant LM. The new calcium antagonist isradipine effect on blood pressure and the left ventricle in black hypertensive patients . Am J Hypertens. 3:1990;8-15.
10. Moser M, Setaro JF. Antihypertensive drug therapy and regression of left ventricular hypertrophy a review with a focus on diuretics . Eur Heart J. 12:1991;1034-1039.
11. Massie BM. Effect of diuretic therapy on hypertensive left ventricular hypertrophy. Eur Heart J. 13:(Suppl G):1992;53-60.
12. Drayer JIM, Gardin JM, Weber MA, Aronow WS. Changes in ventricular septal thickness during diuretic therapy. Clin Pharmacal Ther. 32:1982;283-288.
13. Dahlof B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients a meta-analysis of 109 treatment studies . Am J Hypertens. 5:1992;95-110.
14. Schmieder RE, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension a meta-analysis of randomized double-blind studies . JAMA. 275:1996;1507-1513.
15. Liebson PR. Clinical studies of drug reversal of hypertensive left ventricular hypertrophy. Am J Hypertens. 3:1990;512-517.
16. Liebson PR, Grandits G, Prineas R, et al. Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the treatment of mild hypertension study (TOMHS). Circulation. 87:1993;476-486.
17. Gottdiener JS, Reda DJ, Materson BJ, et al. Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. J Am Coll Cardiol. 24:1994;1492-1498.
18. Devereux RB, Lutas EM, Casale RN, et al. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol. 4:1984;1222-1230.
19. Myreng Y, Smiseth OA. Assessment of left ventricular relaxation by Doppler echocardiography. Circulation. 81:1990;260-266.
20. Sahn DJ, DeMaria A, Kisslo J, Weyman A, for the Committee on M-Mode Standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83.
21. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy comparison to necropsy findings. Am J Cardiol. 57:1986;450-458.
22. Boothby WM, Sandiford RB. Nomographic charts for the calculation of the metabolic rate by the gasometer method. Boston Med Surg J. 185:1921;337-354.
23. Reichek N, Wilson J, St John Sutton M, Plappert T, Goldberg S, Hirshfield J. Noninvasive determination of left ventricular end-systolic stress validation of the method and initial application . Circulation. 65:1982;99-108.
24. SAS/STAT Users Guide, Version 6. 4th ed. 1989;SAS Institute, Cary (NC).
25. Ganau A, Devereux RB, Pickering TG, et al. Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation. 81:1990;25-36.
26. Devereux RB, Pennert K, Cody RJ. Relation of renin-angiotensin system activity to left ventricular hypertrophy and function in experimental and human hypertension. J Clin Hypertens. 3:1987;87-103.
27. Burnier M, Brunner HR. Neurohormonal consequences of diuretics in different cardiovascular syndromes. Eur Heart J. 13:(Suppl G):1992;28-33.
28. Liebson PR, Grandits GA, Dianzumba S, et al. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Circulation. 91:1995;698-706.
29. Neaton JD, Grimm RJ Jr, Prineas RJ, et al., for the Treatment of Mild Hypertension Study Research Group. Treatment of Mild Hypertension Study: final results. JAMA 1993;270:713-24.
30. Materson BJ, Reda DJ, Cushman WC, et al., for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. N Engl J Med 1993;328:914-21.
31. Gottdiener J, Reda D, Massie BM, Materson BJ, Williams DW, Anderson RJ, for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. Circulation 1997;95:2007-14.
32. Schulman S, Weiss J, Becker L, et al. The effects of antihypertensive therapy on left ventricular mass in elderly patients. N Engl J Med. 322:1990;1350-1356.
33. Thomas JD, Weyman AE. Echocardiographic Doppler evaluation of left ventricular diastolic function. Circulation. 84:1991;977-990.
34. Prevention of stroke by antihypertensive drug treatment in older persons with hypertension Systolic Hypertension in the Elderly Program (SHEP) . JAMA. 265:1991;3255-3263.
35. Medical Research Council trial treatment of hypertension in older adults principal results . BMJ. 304:1992;405-412.
36. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 153:1993;154-183.